BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31714640)

  • 1. Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
    Aícua-Rapún I; André P; Rossetti AO; Ryvlin P; Hottinger AF; Decosterd LA; Buclin T; Novy J
    Ann Neurol; 2020 Jan; 87(1):22-29. PubMed ID: 31714640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
    Jacob S; Nair AB
    Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of the newer antiepileptic drugs.
    Johannessen SI; Battino D; Berry DJ; Bialer M; Krämer G; Tomson T; Patsalos PN
    Ther Drug Monit; 2003 Jun; 25(3):347-63. PubMed ID: 12766564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.
    Patsalos PN; Spencer EP; Berry DJ
    Ther Drug Monit; 2018 Oct; 40(5):526-548. PubMed ID: 29957667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.
    Jannuzzi G; Cian P; Fattore C; Gatti G; Bartoli A; Monaco F; Perucca E
    Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in blood-level monitoring: reexamining its role in the treatment of epilepsy.
    Glauser TA; Pippenger CE
    Epilepsia; 2000; 41 Suppl 8():S6-15. PubMed ID: 11092608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium.
    Tomson T; Battino D
    Clin Pharmacokinet; 2007; 46(3):209-19. PubMed ID: 17328580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
    Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
    Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Using Oral Fluid for Therapeutic Drug Monitoring of Antiepileptic Drugs.
    Patrick M; Parmiter S; Mahmoud SH
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):205-223. PubMed ID: 33569746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs.
    Johannessen SI
    Ther Drug Monit; 2005 Dec; 27(6):710-3. PubMed ID: 16404799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
    Patsalos PN; Berry DJ
    Ther Drug Monit; 2013 Feb; 35(1):4-29. PubMed ID: 23288091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
    Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
    Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.
    Johannessen Landmark C; Johannessen SI; Patsalos PN
    Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):227-238. PubMed ID: 32054370
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study.
    Nilsson L; Bergman U; Diwan V; Farahmand BY; Persson PG; Tomson T
    Epilepsia; 2001 May; 42(5):667-73. PubMed ID: 11380576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited place for plasma monitoring of new antiepileptic drugs in clinical practice.
    Striano S; Striano P; Capone D; Pisani F
    Med Sci Monit; 2008 Oct; 14(10):RA173-8. PubMed ID: 18830207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.